Richter Syndrome - 14 Studies Found Completed : A Phase II Study of Venetoclax in Combination With Dose-adjusted EPOCH-R for Patients With Richter's Syndrome : Richter Syndrome : 2017-02-10 : Drug: Venetoclax Venetoclax is Completed : Study of Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone (CHOP) With Ofatumumab in Patients With Richter's Syndrome : Richter's Syndrome : 2010-07-22 : Drug: Ofatumumab 1000mg vials (50ml @ 20mg/ml), or 100mg v Not yet recruiting : Study of Ibrutinib & Obinutuzumab With/Without CHOP for Richter's Transformation or Richter's Syndrome Patients : Richter Syndrome : 2017-04-04 : Drug: Obinutuzumab 100 mg on d Not yet recruiting : Obinutuzumab, High Dose Methylprednisolone (HDMP), and Lenalidomide for the Treatment of Patients With Richter's Syndrome : Richter's Syndrome CLL : 2017-04-10 : Drug: Obinutuzumab, lenalidomide, HDMP Completed : Study of Pembrolizumab (MK-3475) in Participants With Relapsed or Refractory Primary Mediastinal Large B-cell Lymphoma or Relapsed or Refractory Richter Syndrome (MK-3475-170/KEYNOTE-170) : Mediastinal Large B-cell Lymphoma Richter Syndrome : 2015-10-14 : Biological: Pembrolizumab IV infusion Other Names: Terminated : Selinexor in Initial or Relapsed/Refractory Richter's Transformation : Richter's Transformation : 2014-05-13 : Drug: selinexor 60 mg, may be increased to 80 mg after Cycle 1 Terminated : PNT2258 for Treatment of Patients With Richter's Transformation (Brighton) : Richter's Transformation : 2015-02-26 : Drug: PNT2258 Not yet recruiting : Study of Blinatumomab in Richter Transformation : Hematopoietic/Lymphoid Cancer Richter's Transformation : 2017-04-14 : Drug: Blinatumomab Not yet recruiting : Obinutuzumab Containing Conditioning Regimen for Patients With Poor Risk CLL or Richter`s Transformation Requiring Allogeneic Stem Cell Transplantation : Chronic Lymphocytic Leukemia Richter`s Transformation : 2017-05-12 : Biological: Obinutuzumab Obinutuzumab i.v.: 100 mg, 900 mg, 1000 mg Completed : VNP40101M in Treating Patients With Richter Syndrome or Refractory or Relapsed Chronic Lymphocytic Leukemia or Other Lymphoproliferative Disorders : Leukemia Lymphoma : 2006-03-15 : Drug: laromustine Next >>>
